SST and neoplasm: Since the physical properties of 90Y suggest that this radionuclide will be more effective in larger tumor masses and 177Lu in smaller tumor masses and metastases, the combination treatment of 90Y- and 177Lu-labeled SST analogs seems a reasonable option for managing tumors of varying sizes and SSTR subtypes.